MASLD and MASH: prioritising a global public health threat

Data

23/09/2024

Hora

08:00 - 10:30 h

Lloc

Paramount Club, 1301 6th Ave, New York, NY 10019

Join Economist Impact for ‘MASLD and MASH: prioritising a global public health threat’, supported by the Barcelona Institute for Global Health (ISGlobal). 

The event is scheduled for September 23 2024 from 08:00 - 10:30 h in New York and will explore the critical public health threats posed by MASLD (metabolic dysfunction-associated steatotic liver disease) and MASH (metabolic dysfunction-associated steatohepatitis), diseases that affect one in three adults worldwide.

It will bring together senior global stakeholders (Government [including policymakers, regulators and influencers], Civil Society and/or Patient Organizations, Multilateral Organisations [e.g., UN or NCD-related], Healthcare providers) to discuss the future outlook and policies required to reduce the environmental, social, economic, and human contributors to these diseases.

Broad themes for the session include:

• The social and economic consequences: What are the impacts of leaving MASLD and MASH unaddressed on both societal and economic levels?
• Raising awareness: How can awareness around MASLD and MASH be improved to encourage more action by governments, healthcare providers, and civil society?
• Building a cohesive community: How can a more cohesive community of practice around MASLD and MASH be developed, nurtured, and supported?
• Policy development: What types of policies can be implemented to reduce the environmental, social, economic, and human contributors to MASLD?

Speakers 

• Vanessa Garcia Larsen, Unit Chief on Risk Factors and Nutrition, Department of Noncommunicable Diseases and Mental Health, Pan American Health Organization
• Jeffrey V. Lazarus, Head of Public Health Liver Group, ISGlobal; Professor of Global Health, CUNY SPH; Chair, Healthy Livers Healthy Lives coalition
• Arun J. Sanyal, Director, Stravitz-Sanyal Institute for Liver Disease and Metabolic Health, Virginia Commonwealth University School of Medicine
• Lorraine Stiehl - CEO of the American Liver Foundation
• Johanna Ralston - CEO of World Obesity Foundation
   

Register now!